BAM
KDNY

Belpointe Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Belpointe Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-107
Closed -$2.48K – 3664
2023
Q1 		$2.48K Buy
107
+24
+29% +$556 ﹤0.01% 3255
2022
Q4 		$2.18K Buy
+83
New +$2.18K ﹤0.01% 3229